-
2
-
-
0036831826
-
The pathogenesis of pituitary tumors
-
Asa SL, Ezzat S 2002 The pathogenesis of pituitary tumors. Nat Rev Cancer 2:836-849
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 836-849
-
-
Asa, S.L.1
Ezzat, S.2
-
3
-
-
0023522307
-
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
-
Vallar L, Spada A, Giannattasio G 1987 Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-568
-
(1987)
Nature
, vol.330
, pp. 566-568
-
-
Vallar, L.1
Spada, A.2
Giannattasio, G.3
-
4
-
-
0026523527
-
Ras mutations in human pituitary tumors
-
Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL 1992 Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 174:914-919
-
(1992)
J Clin Endocrinol Metab
, vol.174
, pp. 914-919
-
-
Karga, H.J.1
Alexander, J.M.2
Hedley-Whyte, E.T.3
Klibanski, A.4
Jameson, J.L.5
-
5
-
-
0034980274
-
Tumor suppressor loss in pituitary tumors
-
Alexander JM 2001 Tumor suppressor loss in pituitary tumors. Brain Pathol 11:342-355
-
(2001)
Brain Pathol
, vol.11
, pp. 342-355
-
-
Alexander, J.M.1
-
6
-
-
0028912517
-
Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas
-
Ezzat S, Smyth HS, Ramyar L, Asa SL 1995 Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 80:878-884
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 878-884
-
-
Ezzat, S.1
Smyth, H.S.2
Ramyar, L.3
Asa, S.L.4
-
7
-
-
0034980120
-
The role of hormones, growth factors and their receptors in pituitary tumorigenesis
-
Ezzat S 2001 The role of hormones, growth factors and their receptors in pituitary tumorigenesis. Brain Pathol 11:356-370
-
(2001)
Brain Pathol
, vol.11
, pp. 356-370
-
-
Ezzat, S.1
-
9
-
-
0027050480
-
Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity
-
Givol D, Yayon A 1992 Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369
-
(1992)
FASEB J
, vol.6
, pp. 3362-3369
-
-
Givol, D.1
Yayon, A.2
-
10
-
-
0030904029
-
Altered expression of fibroblast growth factor receptors in human pituitary adenomas
-
Abbass SA, Asa SL, Ezzat S 1997 Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 82:1160-1166
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 1160-1166
-
-
Abbass, S.A.1
Asa, S.L.2
Ezzat, S.3
-
11
-
-
0036144332
-
Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis
-
Ezzat S, Zheng L, Zhu XF, Wu GE, Asa SL 2002 Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109:69-78
-
(2002)
J Clin Invest
, vol.109
, pp. 69-78
-
-
Ezzat, S.1
Zheng, L.2
Zhu, X.F.3
Wu, G.E.4
Asa, S.L.5
-
12
-
-
0041924034
-
Ikaros isoforms in human pituitary tumors: Distinct localization, deacetylation, and activation of the 5′ FGFR4 promoter
-
Ezzat S, Yu S, Asa SL 2003 Ikaros isoforms in human pituitary tumors: distinct localization, deacetylation, and activation of the 5′ FGFR4 promoter. Am J Pathol 163:1177-1184
-
(2003)
Am J Pathol
, vol.163
, pp. 1177-1184
-
-
Ezzat, S.1
Yu, S.2
Asa, S.L.3
-
13
-
-
0037490204
-
Pituitary tumor AP-2α recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4
-
Yu S, Asa SL, Weigel RJ, Ezzat S 2003 Pituitary tumor AP-2α recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4. J Biol Chem 278:19597-19602
-
(2003)
J Biol Chem
, vol.278
, pp. 19597-19602
-
-
Yu, S.1
Asa, S.L.2
Weigel, R.J.3
Ezzat, S.4
-
14
-
-
0037236849
-
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently
-
Oxf
-
Bradley KJ, Wass JA, Turner HE 2003 Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 58:59-64
-
(2003)
Clin Endocrinol
, vol.58
, pp. 59-64
-
-
Bradley, K.J.1
Wass, J.A.2
Turner, H.E.3
-
15
-
-
0030789239
-
Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study
-
Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J 1997 Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102-2107
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 2102-2107
-
-
Delgrange, E.1
Trouillas, J.2
Maiter, D.3
Donckier, J.4
Tourniaire, J.5
-
16
-
-
0030770641
-
Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma
-
Ahmed NU, Ueda M, Ito A, Ohashi A, Funasaka Y, Ichihashi M 1997 Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma. Melanoma Res 7:299-305
-
(1997)
Melanoma Res
, vol.7
, pp. 299-305
-
-
Ahmed, N.U.1
Ueda, M.2
Ito, A.3
Ohashi, A.4
Funasaka, Y.5
Ichihashi, M.6
-
17
-
-
0032954333
-
Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
-
Giri D, Ropiquet F, Ittmann M 1999 Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5:1063-1071
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1063-1071
-
-
Giri, D.1
Ropiquet, F.2
Ittmann, M.3
-
18
-
-
0028332782
-
Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme
-
Morrison RS, Yamaguchi F, Bruner JM, Tang M, McKeehan W, Berger MS 1994 Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 54:2794-2799
-
(1994)
Cancer Res
, vol.54
, pp. 2794-2799
-
-
Morrison, R.S.1
Yamaguchi, F.2
Bruner, J.M.3
Tang, M.4
McKeehan, W.5
Berger, M.S.6
-
19
-
-
0028096172
-
Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas
-
Yamaguchi F, Saya H, Bruner JM, Morrison RS 1994 Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91:484-488
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 484-488
-
-
Yamaguchi, F.1
Saya, H.2
Bruner, J.M.3
Morrison, R.S.4
-
20
-
-
0029867434
-
Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours
-
Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, Nakahara M, Takada K 1996 Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours. J Pathol 178:429-436
-
(1996)
J Pathol
, vol.178
, pp. 429-436
-
-
Myoken, Y.1
Myoken, Y.2
Okamoto, T.3
Sato, J.D.4
Kan, M.5
McKeehan, W.L.6
Nakahara, M.7
Takada, K.8
-
21
-
-
0031925523
-
Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: Difference between neoplasms and hyperplastic lesions
-
Shingu K, Fujimori M, Ito K, Hama Y, Kasuga Y, Kobayashi S, Itoh N, Amano J 1998 Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions. Endocr J 45:35-43
-
(1998)
Endocr J
, vol.45
, pp. 35-43
-
-
Shingu, K.1
Fujimori, M.2
Ito, K.3
Hama, Y.4
Kasuga, Y.5
Kobayashi, S.6
Itoh, N.7
Amano, J.8
-
22
-
-
17744412020
-
The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer
-
Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M, Oka T 1998 The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89:28-34
-
(1998)
Clin Immunol Immunopathol
, vol.89
, pp. 28-34
-
-
Yoshimura, N.1
Sano, H.2
Hashiramoto, A.3
Yamada, R.4
Nakajima, H.5
Kondo, M.6
Oka, T.7
-
23
-
-
0031844173
-
Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis
-
Kornmann M, Beger HG, Korc M 1998 Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 17:169-175
-
(1998)
Pancreas
, vol.17
, pp. 169-175
-
-
Kornmann, M.1
Beger, H.G.2
Korc, M.3
-
24
-
-
0033845246
-
Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer
-
Shin EY, Lee BH, Yang JH, Shin KS, Lee GK, Yun HY, Song YJ, Park SC, Kim EG 2000 Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer. J Cancer Res Clin Oncol 126:519-528
-
(2000)
J Cancer Res Clin Oncol
, vol.126
, pp. 519-528
-
-
Shin, E.Y.1
Lee, B.H.2
Yang, J.H.3
Shin, K.S.4
Lee, G.K.5
Yun, H.Y.6
Song, Y.J.7
Park, S.C.8
Kim, E.G.9
-
25
-
-
0027223454
-
Amplification of fgfr4 gene in human breast and gynecological cancers
-
Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovirta P, Nevanlinna H 1993 Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54:378-382
-
(1993)
Int J Cancer
, vol.54
, pp. 378-382
-
-
Jaakkola, S.1
Salmikangas, P.2
Nylund, S.3
Partanen, J.4
Armstrong, E.5
Pyrhonen, S.6
Lehtovirta, P.7
Nevanlinna, H.8
-
26
-
-
0028799870
-
Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas
-
Ohta T, Yamamoto M, Numata M, Iseki S, Tsukioka Y, Miyashita T, Kayahara M, Nagakawa T, Miyazaki I, Nishikawa K, Yoshitake Y 1995 Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas. Br J Cancer 72:824-831
-
(1995)
Br J Cancer
, vol.72
, pp. 824-831
-
-
Ohta, T.1
Yamamoto, M.2
Numata, M.3
Iseki, S.4
Tsukioka, Y.5
Miyashita, T.6
Kayahara, M.7
Nagakawa, T.8
Miyazaki, I.9
Nishikawa, K.10
Yoshitake, Y.11
-
27
-
-
0036212775
-
Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas
-
Yamada SM, Yamada S, Hayashi Y, Takahashi H, Teramoto A, Matsumoto K 2002 Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas. Neurol Res 24:244-248
-
(2002)
Neurol Res
, vol.24
, pp. 244-248
-
-
Yamada, S.M.1
Yamada, S.2
Hayashi, Y.3
Takahashi, H.4
Teramoto, A.5
Matsumoto, K.6
-
28
-
-
0025838084
-
Alternative splicing generates at least five different isoforms of the human basic-FGF receptor
-
Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D 1991 Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6:1195-1202
-
(1991)
Oncogene
, vol.6
, pp. 1195-1202
-
-
Eisemann, A.1
Ahn, J.A.2
Graziani, G.3
Tronick, S.R.4
Ron, D.5
-
29
-
-
0027198248
-
Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy
-
Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL 1993 Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522
-
(1993)
Mol Cell Biol
, vol.13
, pp. 4513-4522
-
-
Yan, G.1
Fukabori, Y.2
McBride, G.3
Nikolaropolous, S.4
McKeehan, W.L.5
-
30
-
-
0029945085
-
Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II
-
Webster MK, D'Avis PY, Robertson SC, Donoghue DJ 1996 Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 16:4081-4087
-
(1996)
Mol Cell Biol
, vol.16
, pp. 4081-4087
-
-
Webster, M.K.1
D'Avis, P.Y.2
Robertson, S.C.3
Donoghue, D.J.4
-
31
-
-
0030871359
-
Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2
-
Mangasarian K, Li Y, Mansukhani A, Basilico C 1997 Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J Cell Physiol 171:117-125
-
(1997)
J Cell Physiol
, vol.171
, pp. 117-125
-
-
Mangasarian, K.1
Li, Y.2
Mansukhani, A.3
Basilico, C.4
-
32
-
-
0032543288
-
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome
-
Chun K, Siegel-Bartelt J, Chitayat D, Phillips J, Ray PN 1998 FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet 77:219-224
-
(1998)
Am J Med Genet
, vol.77
, pp. 219-224
-
-
Chun, K.1
Siegel-Bartelt, J.2
Chitayat, D.3
Phillips, J.4
Ray, P.N.5
-
33
-
-
0029764116
-
Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains
-
Neilson KM, Friesel R 1996 Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem 271:25049-25057
-
(1996)
J Biol Chem
, vol.271
, pp. 25049-25057
-
-
Neilson, K.M.1
Friesel, R.2
-
34
-
-
0032841519
-
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
-
Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP, Radvanyi F 1999 Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 23:18-20
-
(1999)
Nat Genet
, vol.23
, pp. 18-20
-
-
Cappellen, D.1
De Oliveira, C.2
Ricol, D.3
De Medina, S.4
Bourdin, J.5
Sastre-Garau, X.6
Chopin, D.7
Thiery, J.P.8
Radvanyi, F.9
-
35
-
-
0035328856
-
Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
-
Jang JH, Shin KH, Park JG 2001 Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res 61:3541-3543
-
(2001)
Cancer Res
, vol.61
, pp. 3541-3543
-
-
Jang, J.H.1
Shin, K.H.2
Park, J.G.3
-
36
-
-
0027955135
-
Fibroblast growth factor receptors have different signaling and mitogenic potentials
-
Wang JK, Gao G, Goldfarb M 1994 Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14:181-188
-
(1994)
Mol Cell Biol
, vol.14
, pp. 181-188
-
-
Wang, J.K.1
Gao, G.2
Goldfarb, M.3
-
37
-
-
0028332812
-
Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1
-
Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG, Alitalo K 1994 Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem 269:18320-18326
-
(1994)
J Biol Chem
, vol.269
, pp. 18320-18326
-
-
Vainikka, S.1
Joukov, V.2
Wennstrom, S.3
Bergman, M.4
Pelicci, P.G.5
Alitalo, K.6
-
38
-
-
0036468871
-
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele
-
Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M, Knyazeva T, Muller S, Gartner S, Sures I, Wang H, Imyanitov E, Haring HU, Knayzev P, Iacobelli S, Hofler H, Ullrich A 2002 Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62:840-847
-
(2002)
Cancer Res
, vol.62
, pp. 840-847
-
-
Bange, J.1
Prechtl, D.2
Cheburkin, Y.3
Specht, K.4
Harbeck, N.5
Schmitt, M.6
Knyazeva, T.7
Muller, S.8
Gartner, S.9
Sures, I.10
Wang, H.11
Imyanitov, E.12
Haring, H.U.13
Knayzev, P.14
Iacobelli, S.15
Hofler, H.16
Ullrich, A.17
-
39
-
-
0037191924
-
FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1α
-
Shah RN, Ibbitt JC, Alitalo K, Hurst HC 2002 FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1α. Oncogene 21:8251-8261
-
(2002)
Oncogene
, vol.21
, pp. 8251-8261
-
-
Shah, R.N.1
Ibbitt, J.C.2
Alitalo, K.3
Hurst, H.C.4
-
40
-
-
0031158860
-
Genetic basis of endocrine disease: Pituitary tumor pathogenesis
-
Shimon I, Melmed S 1997 Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab 82:1675-1681
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 1675-1681
-
-
Shimon, I.1
Melmed, S.2
-
41
-
-
0034898556
-
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis
-
Bellosta P, Iwahori A, Plotnikov AN, Eliseenkova AV, Basilico C, Mohammadi M 2001 Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis. Mol Cell Biol 21:5946-5957
-
(2001)
Mol Cell Biol
, vol.21
, pp. 5946-5957
-
-
Bellosta, P.1
Iwahori, A.2
Plotnikov, A.N.3
Eliseenkova, A.V.4
Basilico, C.5
Mohammadi, M.6
-
42
-
-
0029122724
-
Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas
-
McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE 1995 Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479-4488
-
(1995)
Endocrinology
, vol.136
, pp. 4479-4488
-
-
McAndrew, J.1
Paterson, A.J.2
Asa, S.L.3
McCarthy, K.J.4
Kudlow, J.E.5
-
43
-
-
0030060379
-
Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody
-
Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws Jr ER 1996 Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-107
-
(1996)
Neurosurgery
, vol.38
, pp. 99-107
-
-
Thapar, K.1
Kovacs, K.2
Scheithauer, B.W.3
Stefaneanu, L.4
Horvath, E.5
Pernicone, P.J.6
Murray, D.7
Laws Jr., E.R.8
|